Martin I de Bock
Overview
Explore the profile of Martin I de Bock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Styles S, Haszard J, Rose S, Galland B, Wiltshire E, de Bock M, et al.
Contemp Clin Trials
. 2025 Feb;
152:107864.
PMID: 39987959
Aim: The study aimed to identify active intervention components to improve glucose sensor time in range (TIR; 70-180 mg/dL [3.9-10.0 mmol/L]) by ≥5 % among adolescents and young adults (13...
2.
Johansson M, March de Ribot F, Sime M, Boucsein A, Zhou Y, Jefferies C, et al.
Diabetes Technol Ther
. 2025 Feb;
PMID: 39925093
Rapid improvements in glucose control may lead to early worsening of diabetic retinopathy (EWDR). There is a need to demonstrate safety in people commencing automated insulin delivery (AID) due to...
3.
Zhou Y, Boucsein A, Michaels V, Gray M, Jefferies C, Wiltshire E, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):2138-2146.
PMID: 39831344
Aims: This study aimed to identify key factors with the greatest influence on glycaemic outcomes in young individuals with type 1 diabetes (T1D) and very elevated glycaemia after 3 months...
4.
Jenkins A, Januszewski A, Kirby A, Hendrieckx C, McAuley S, Lee M, et al.
Intern Med J
. 2024 Nov;
55(1):148-153.
PMID: 39601386
Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID)...
5.
Lai S, Styles S, Boucsein A, Zhou Y, Michaels V, Jefferies C, et al.
Diabet Med
. 2024 Nov;
42(3):e15448.
PMID: 39587412
Aims: To identify from a parental perspective facilitators and barriers of effective implementation of advanced hybrid closed-loop (AHCL) therapy in children and adolescents with type 1 diabetes (T1D) with elevated...
6.
Wong J, Styles S, Wiltshire E, de Bock M, Boucsein A, Palmer O, et al.
Diabet Med
. 2024 Oct;
42(1):e15449.
PMID: 39377427
Aim: To understand experiences of using second-generation advanced hybrid closed-loop (AHCL) therapy in adolescents and young adults with chronically elevated glucose levels who were previously using multiple daily injections (MDI)...
7.
Boucsein A, Zhou Y, Michaels V, Haszard J, Jefferies C, Wiltshire E, et al.
NEJM Evid
. 2024 Sep;
3(10):EVIDoa2400185.
PMID: 39315863
Background: Automated insulin delivery is the treatment of choice in adults with type 1 diabetes. Data are needed on the efficacy and safety of automated insulin delivery for children and...
8.
Boucsein A, Zhou Y, Haszard J, Jefferies C, Wiltshire E, Styles S, et al.
J Diabetes Metab Disord
. 2024 Jun;
23(1):1397-1407.
PMID: 38932805
Purpose: Advanced hybrid closed loop (AHCL) systems have the potential to improve glycemia and reduce burden for people with type 1 diabetes (T1D). Children and youth, who are at particular...
9.
Sergel-Stringer O, Wheeler B, Styles S, Boucsein A, Lever C, Paul R, et al.
J Diabetes Metab Disord
. 2024 Jun;
23(1):1163-1171.
PMID: 38932793
Aims: To explore the lived experiences of initiating real-time continuous glucose monitoring (rt-CGM) use in individuals with type 2 diabetes using insulin. Methods: Twelve semi-structured interviews were conducted amongst individuals...
10.
Lever C, Williman J, Boucsein A, Watson A, Sampson R, Sergel-Stringer O, et al.
Diabet Med
. 2024 May;
41(8):e15348.
PMID: 38758653
Aims: To investigate the impact of real-time continuous glucose monitoring (rtCGM) on glycaemia in a predominantly indigenous (Māori) population of adults with insulin-requiring type 2 diabetes (T2D) in New Zealand....